HOME >> BIOLOGY >> NEWS
Ronald Cape to receive 2007 Biotechnology Heritage Award

PHILADELPHIA and WASHINGTON, D.C.8 May 2007Chemical Heritage Foundation (CHF) and the Biotechnology Industry Organization (BIO) will present the ninth annual Biotechnology Heritage Award to Ronald Cape, cofounder of Cetus Corporation. Cape is a true visionary, a pioneer, and an entrepreneur gifted with considerable research and business skills. The award, sponsored by Invitrogen Corporation, will be presented at the 2007 BIO International Convention in Boston.

"Cetus Corporation is widely recognized as the first biotechnology company," said James C. Greenwood, president of BIO. "Ron Cape saw the potential of biotechnology even before recombinant DNA. He helped to create a new kind of company and with it launched the creation of a whole new industry."

About Ronald E. Cape

Cape, a partner at PureTech Ventures in Boston , cofounded Cetus in 1971 and served as its chairman for 20 years and CEO for 13 years, until Cetus merged with Chiron Corporation in 1991. Cetus was a pioneer in genetic engineering, developing a technology that was ultimately awarded a Nobel Prize. Cape was the founding chairman of Darwin Molecular Corporation, which was later sold to Chiroscience plc. He serves on the board of EntreMed, Inc. and Neurobiological Technologies, Inc. He also serves as a director for several privately held companies. Cape was a founding member of the Industrial Biotechnology Association (now BIO), where he served as president from 1983 to 1985. He is a fellow of the American Academy of Arts and Sciences, the American Academy of Microbiology, and the American Association for the Advancement of Science.

About the Biotechnology Heritage Award

The Biotechnology Heritage Award is presented yearly at a special ceremony during the BIO Annual International Convention to honor individuals who have contributed significantly to the growth of biotechnology through discovery, innovation, commercialization, and/or public und
'"/>

Contact: Neil Gussman
neilg@chemheritage.org
215-873-8262
Chemical Heritage Foundation
8-May-2007


Page: 1 2

Related biology news :

1. Joslins C. Ronald Kahn, MD, to discuss genetics of obesity at AACE meeting
2. Frances highest scientific honor awarded this year to Salk Institute scientist Ronald M. Evans
3. Carnegie Mellons Peter Adams receives EPA research grant
4. 2007 EURYI: 20 young researchers to receive Nobel Prize-sized awards for breakthrough ideas
5. Fedoroff, of Penn State, to receive National Medal of Science
6. Philadelphia ecologist receives top Mongolia honor
7. Nearly 90 percent of babies receive recommended newborn screening tests
8. VIB scientist receives major research grant
9. Maynard Olson receives $500,000 Gruber Genetics Prize
10. University of Cincinnati receives $1.7M to research molecular treatment of brain injury
11. UGA scientists receive $20M in federal bioenergy initiative

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Ronald Cape receive Biotechnology Heritage Award

(Date:6/24/2015)... Biometry authentication provider KeyLemon today announced ... one face in. Logo - ... in, entering the expanding biometric authentication market in ... answer to the password problem. With advanced face ... KeyLemon, one face in allows users to securely ...
(Date:6/23/2015)... BEACH GARDENS, Fla. , June 23, ... multi-factor identity management and authentication solutions, today announced ... Altus strong, multi-factor authentication solution.  The enhancements ... of use of the DigitalPersona Altus platform ... biometric reader compatibility. In today,s ...
(Date:6/17/2015)... , June 17, 2015 QIAGEN ... launched new Investigator ® STR assay kits for analysis ... United States . The new genetic fingerprint kits provide ... (short tandem repeats or STRs) for DNA matching. They incorporate ... of DNA in each sample, a novel QIAGEN technology that ...
Breaking Biology News(10 mins):KeyLemon Announces Partnership With Biometric Password Solution onefacein 2Crossmatch Releases Enhanced DigitalPersona Altus Advanced Authentication Functionality 2QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 2QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 3QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 4QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 5
(Date:7/2/2015)... PALO ALTO, Calif. (PRWEB) , ... July 02, 2015 , ... ... designed to improve an individual’s quality of sleep, launched its Indiegogo campaign on June ... and functionality: Luzi's voice command technology makes it effortless to use, while the integration ...
(Date:7/1/2015)... , ... July 01, 2015 , ... It is now ... (TBI) using single photon emission computed tomography (SPECT) according to researchers from ... which examined over 20,000 brain scans and is believed to be the largest brain ...
(Date:7/1/2015)...   Decision Resources Group finds that ... are its oral administration, alternative mechanism of action, ... rheumatologists. Otezla was the first oral therapy specifically ... psoriatic arthritis in the United States ... conventional oral treatments including disease-modifying antirheumatic drugs (DMARDs), ...
(Date:7/1/2015)... and BANGALORE, India , July 1, ... company that uses next generation sequencing technology to empower ... A. Storrer as chief executive officer. In his ... be responsible for all strategy, business expansion and worldwide ... has served as Strand,s chairman and CEO since its ...
Breaking Biology Technology:Luzi Smart Lamp Recently Launched Indiegogo Campaign 2Luzi Smart Lamp Recently Launched Indiegogo Campaign 3Brain Scans Can Tell Post-Traumatic Stress Disorder and Traumatic Brain Injury Apart According to New Research by Amen Clinics 2Brain Scans Can Tell Post-Traumatic Stress Disorder and Traumatic Brain Injury Apart According to New Research by Amen Clinics 3Brain Scans Can Tell Post-Traumatic Stress Disorder and Traumatic Brain Injury Apart According to New Research by Amen Clinics 4Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 2Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 3Strand Life Sciences Names Scott A. Storrer CEO as Company Continues Global Expansion with Focus on Precision Medicine Product 2Strand Life Sciences Names Scott A. Storrer CEO as Company Continues Global Expansion with Focus on Precision Medicine Product 3
Cached News: